Article

Body size and metabolic differences in Maine Coon cats with and without hypertrophic cardiomyopathy

1Department of Clinical Sciences, Tufts Cummings School of Veterinary Medicine, North Grafton, MA, USA.
Journal of Feline Medicine & Surgery (Impact Factor: 1.16). 02/2013; 15(2):74-80. DOI: 10.1177/1098612X12460847

ABSTRACT

An interplay between growth, glucose regulation and hypertrophic cardiomyopathy (HCM) may exist, but has not been studied in detail. The purpose of this study was to characterize morphometric features, insulin-like growth factor-1 (IGF-1) and glucose metabolism in Maine Coon cats with HCM. Body weight, body condition score (BCS), head length and width, and abdominal circumference were measured in Maine Coon cats >2 years of age. Echocardiography and thoracic radiography (for measurement of humerus length, and fourth and twelfth vertebrae length) were also performed. Blood was collected for biochemistry profile, DNA testing, insulin and IGF-1. Sixteen of 63 cats had HCM [myosin binding protein C (MYBPC)+, n = 3 and MYBPC−, n = 13] and 47/63 were echocardiographically normal (MYBPC+, n = 17 and MYBPC−, n = 30). There were no significant differences in any measured parameter between MYBPC+ and MYBPC− cats. Cats with HCM were significantly older (P <0.001), heavier (P = 0.006), more obese (P = 0.008), and had longer humeri (P = 0.02) compared with the HCM− group. Cats with HCM also had higher serum glucose (P = 0.01), homeostasis model assessment (HOMA) and IGF-1 (P = 0.01) concentrations, were from smaller litters (P = 0.04), and were larger at 6 months (P = 0.02) and at 1 year of age (P = 0.03). Multivariate analysis revealed that age (P <0.001), BCS (P = 0.03) and HOMA (P = 0.047) remained significantly associated with HCM. These results support the hypothesis that early growth and nutrition, larger body size and obesity may be environmental modifiers of genetic predisposition to HCM. Further studies are warranted to evaluate the effects of early nutrition on the phenotypic expression of HCM.

Download full-text

Full-text

Available from: John E Rush
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Diet might influence progression of hypertrophic cardiomyopathy (HCM).Objective To investigate whether diet composition could alter clinical, biochemical, or echocardiographic variables in cats with HCM.AnimalsTwenty-nine cats with HCM (International Small Animal Cardiac Health Council stage 1b) examined at a university teaching hospital.Methods Randomized, placebo-controlled trial. After physical examination, echocardiogram, and blood collection, cats were randomized to 1 of 3 diets, which varied in carbohydrate and fat content and ingredients. Measurements were repeated after 6 months.ResultsThere were no significant differences among the 3 groups at baseline. After 6 months, there were no significant changes in the primary endpoints, left ventricular free wall (Group A, P = .760; Group B, P = .475; Group C, P = .066) or interventricular septal thickness in diastole (Group A, P = .528; Group B, P = .221; Group C, P = .097). Group A had significant increases in BUN (P = .008) and cholesterol (P = .021), while Group B had significant increases in BUN (P = .008), cholesterol (P = .007), and triglycerides (P = .005), and significant decreases in NT-proBNP (P = .013) and hs-troponin I (P = .043). Group C had significant decreases in body weight (P = .021), left atrial dimension (P = .035), interventricular septal thickness in systole (P = .038), and liver enzymes (P = .034–.038).Conclusions and Clinical ImportanceThese data suggest that diet might influence some clinical, biochemical, and echocardiographic variables in cats with HCM.
    No preview · Article · Apr 2014 · Journal of Veterinary Internal Medicine
  • [Show abstract] [Hide abstract]
    ABSTRACT: Overweight and obesity in dogs and cats seems to be an increasing problem in small animal practice. Although an enhanced body weight is sometimes considered not to be a direct disease, it can be associated with various adverse consequences such as diabetes mellitus, Osteoarthritis, cardiovascular problems or reduced life expectancy. In general, an evaluation of the body condition of an animal should be based on regular weighing and the so-called Body Condition Scoring System. Further methods for the measurement of the body fat percentage of an animal (dual energy X-ray absorptiometry, sonography or bioelectrical impedance analysis) have not been standardised for practice or require high investment costs for the equipment. Dietetic measures for reducing body weight focus primarily on a restriction of the animal's daily energy intake, whereby either the amount of the normal feed can be restricted or a specific weight-reduction diet can be used. An adequate weight-reduction diet should have a lower energy density compared to a Standard diet. This can be achieved by it having a lower fat concentration or additionally a higher Proportion of crude fibre. Dietary fibre can also enhance the feeling of satiety in dogs and cats. Soluble fibre (e.g. pectins in apples and carrots) can inhibit gastric emptying and prolong the residence time of the digesta in the intestine. Insoluble fibre that can be provided with cellulose or wheat bran increases the volume of the gastrointestinal contents, which may activate the Stretch receptors and mediate a feeling of satiety. Finally, a weight-reduction diet should have a higher crude protein concentration than a Standard diet, since this can prevent the loss of lean body mass during weight reduction.The supportive effects of specific nutrients like carnitine, diacylglycerols or chromium on weight loss in dogs and cats have only been rarely investigated and should be considered in future studies. Besides the dietetic measures, enhanced physical activity should also be included in the weight-reduction program for dogs and cats, since this can be assumed to have ben-eficial effects on the daily energy expenditure, body condition and metabolic disorders such as insulin resistance. Where appropriate, the drugs mitratapide or dirlotapide can also support weight loss in dogs. In conclusion, weight loss in overweight or obese dogs and cats not only can reduce the risk of secondary diseases, but also can improve the quality of life and lifespan of affected animals.
    No preview · Article · Sep 2014 · Kleintierpraxis
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Cats with hypertrophic cardiomyopathy (HCM) are larger and have higher insulin-like growth factor-1 (IGF-1) concentrations than cats without HCM.Hypothesis/Objectives The aim of this study was to assess echocardiographic findings in a colony of adult cats to determine the relationship between early growth and left ventricular hypertrophy (LVH).AnimalsTwenty-eight neutered adult cats (20 males, 8 females) from a colony ≥3 years of age for which growth curves were available.Methods Case–control study. Physical examination and echocardiography were performed, and body weight, body condition score (BCS), and head length and width were measured. Circulating glucose, insulin, N-terminal pro-B-type natriuretic peptide (NT-proBNP), and IGF-1 concentrations were measured and growth data were collected. Stepwise multivariate analyses were performed.ResultsMean age was 5.2 ± 1.1 years. Current BCSs ranged from 4 to 9 (median, 6) and mean body weight was 4.88 ± 1.29 kg. Variation in body weight was apparent by 6 (mean = 3.26 ± 0.80 kg) and 12 months of age (mean = 4.02 ± 1.02 kg). Cardiac abnormalities included a cardiac murmur (n = 7; 24%), gallop (n = 3; 10%), and arrhythmia (n = 1; 4%). Fourteen of 28 cats (50%) had echocardiographic evidence of LVH. Head width (P = .017), body weight (P < .001), NT-proBNP (P = .023), and IGF-1 (P = .013–.022) were significantly associated with selected measures of LVH.Conclusions and Clinical ImportancePotential associations between body size, IGF-1, LVH, and HCM warrant future prospective studies.
    No preview · Article · Nov 2014 · Journal of Veterinary Internal Medicine
Show more